III International Conference on Psychedelics

The III International Conference on Psychedelics, Fuertedélica, will occur on November 22-23, 2024, in Corralejo, Fuerteventura, Spain. This event is a significant gathering for those interested in the emerging field of psychedelic therapies. With the anticipated authorization of MDMA for medical use in treating PTSD by August 2024 (still in flux), the conference marks the dawn of a transformative era in psychedelic medicine. Attendees will have the opportunity to explore the integration of various psychoactive substances, including psilocybin, LSD, DMT, and ayahuasca, into modern therapeutic practices.

Fuertedélica offers a rich program featuring five roundtable discussions. Leading experts will delve into topics ranging from medical systems incorporating psychoactive plants to contemporary psychedelic culture and drug policies. The event aims to foster dialogue, learning, and a deeper understanding of the multifaceted impacts of psychedelics on mental health and society. The lineup includes internationally renowned professionals, ensuring a diverse and comprehensive exploration of the subject matter.

Set against the stunning backdrop of Fuerteventura, the conference provides formal presentations and facilitates informal interactions among participants. These networking opportunities are designed to encourage the exchange of ideas, formation of alliances, and collaborative projects. Whether through engaging discussions or relaxed social settings, attendees will find ample opportunities to connect and learn from each other.

Fuertedélica invites researchers to present their scientific posters, contributing to the event’s emphasis on cutting-edge research and practical applications. With early bird tickets available, this conference is an unmissable opportunity for anyone passionate about the future of psychedelic therapies. Join us in Fuerteventura to be part of this groundbreaking event and explore the evolving landscape of psychedelics.